Baby Grivet Monkey Kidney (BGM) a new cell line for adaptation of fowl pox virus | ||||
| Benha Veterinary Medical Journal | ||||
| Article 22, Volume 31, Issue 1, September 2016, Page 137-140 PDF (280.88 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/bvmj.2016.31239 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| El-Bagoury G. F.1; El-Nahas E. M.1; Olfat A. Nakhla2; Nesma M. Hassan2 | ||||
| 1Department of virology, Faculty of Veterinary Medicine, Benha University, Egypt | ||||
| 2Veterinary Serum and Vaccine Research Institute, Abbassia, Cairo | ||||
| Abstract | ||||
| The need to economic, sensitive and easily maintained cell cultures use for massive production of fowl pox vaccine was necessary. We adapted Fowl pox virus (FPV) Baudette strain on Primary chicken embryo fibroblast (CEF), Baby Grivet Monkey Kidney cell line (BGM) and African green monkey kidney (Vero) cell lines. The highest virus titers were 106.5 after the 9th passage in CEF and 106.2 after the 12th passage on BGM while Vero cells were abortive to the virus. BGM cells were selected for study cytopathic effect (CPE) and growth kinetic as it easily maintained than primary CEF cells. The characteristic CPE were rounding till 6th passage with intracytoplasmic inclusion by the 7th passage and syncytium formation appeared from the 9th passage till the 13th passage. The virus was highly cell associated for the first 84h post inoculation(PI) with a titer of 104.5 then a maximum titer was 106.2 in cell free portion after 120h PI. In conclusion, BGM were considered a new susceptible cell for growth of FPV with best harvesting time 120h PI to obtain a maximum titer for subsequent vaccine production | ||||
| Keywords | ||||
| Fowl pox virus; CEF; BGM; VERO cell | ||||
|
Statistics Article View: 196 PDF Download: 368 |
||||
